02/09/2024
8:31 PM | IO Biotech (Subject)
Novo Holdings A/S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
7:11 AM | IO Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
4:14 PM | IO Biotech (Subject)
Samsara BioCapital, L.P. (Filed by)
| Form SC 13G | |
11/24/2023
4:37 PM | Burkavage Brian (Reporting)
IO Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
3:47 PM | Collins Helen Louise (Reporting)
IO Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
3:41 PM | Collins Helen Louise (Reporting)
IO Biotech (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/13/2023
7:10 AM | IO Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
09/12/2023
3:06 PM | IO Biotech (Filer)
| Form 424B2
Transaction specifc information for a delayed shelf offering | |
09/10/2023
11:15 PM | IO Biotech (Filer)
| Form EFFECT | |
09/07/2023
9:36 AM | IO Biotech (Subject)
Kurma Partners (Filed by)
| Form SC 13G | |
08/30/2023
3:16 PM | IO Biotech (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/21/2023
2:40 PM | IO Biotech (Issuer)
Kurma Partners (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/16/2023
3:15 PM | IO Biotech (Subject)
Stonepine Capital Management, LLC (Filed by)
| Form SC 13G | |
08/15/2023
5:02 PM | Hunter Heidi (Reporting)
IO Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
4:57 PM | Hunter Heidi (Reporting)
IO Biotech (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2023
2:15 PM | HBM Healthcare Investments Ltd. (0001232258) (Filed by)
IO Biotech (Subject)
| Form SC 13G/A | |
08/14/2023
2:45 PM | IO Biotech (Subject)
Lundbeckfond Invest A/S (Filed by)
| Form SC 13D/A | |
08/14/2023
2:45 PM | HBM Healthcare Investments Ltd. (0001232258) (Filed by)
IO Biotech (Subject)
| Form SC 13G/A | |
08/11/2023
8:22 PM | IO Biotech (Issuer)
Lundbeckfond Invest A/S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/11/2023
8:24 PM | Elling Christian E (Reporting)
IO Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/11/2023
7:41 AM | IO Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/11/2023
7:31 AM | IO Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
8:03 AM | IO Biotech (Issuer)
Vivo Capital Fund IX, L.P. (Reporting)
Vivo Capital IX, LLC (Reporting)
Vivo Opportunity Fund Holdings, L.P. (Reporting)
Vivo Opportunity, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2023
7:43 PM | IO Biotech (Issuer)
Zocca Mai-Britt (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2023
7:38 PM | IO Biotech (Issuer)
Smith Devin Whittemore (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2023
7:41 PM | IO Biotech (Issuer)
Sullivan Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2023
7:31 AM | IO Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2023
3:10 PM | Ahmad Qasim Iftikhar (Reporting)
IO Biotech (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/19/2023
3:20 PM | Ahmad Qasim Iftikhar (Reporting)
IO Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
3:05 PM | IO Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2023
7:06 AM | IO Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2023
6:54 PM | Elling Christian E (Reporting)
IO Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
6:54 PM | Glaub Kathleen Sereda (Reporting)
IO Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
6:54 PM | Hirth Peter (Reporting)
IO Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
6:54 PM | IO Biotech (Issuer)
Nielsen Jack (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
6:54 PM | IO Biotech (Issuer)
Smith David V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/14/2023
3:39 PM | IO Biotech (Filer)
| Form PRE 14A | |
03/22/2023
3:40 PM | Al-Hajj Muhammad (Reporting)
IO Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2023
3:26 PM | IO Biotech (Issuer)
Sullivan Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2023
3:21 PM | Burkavage Brian (Reporting)
IO Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2023
3:13 PM | Ehrnrooth Eva (Reporting)
IO Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/20/2023
4:35 PM | IO Biotech (Issuer)
Sullivan Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2023
5:09 AM | IO Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/10/2023
4:29 PM | IO Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2023
3:31 PM | IO Biotech (Filer)
| Form 424B2
Transaction specifc information for a delayed shelf offering | |
02/15/2023
3:33 PM | IO Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2023
11:15 PM | IO Biotech (Filer)
| Form EFFECT | |
